Required Sublicensing. If Licensee is unable or unwilling to serve or develop a potential market or market territory for which there is a company willing to be a Permitted Sublicensee, Licensee will, at CSMC’s request, negotiate in good faith a sublicense with any such Permitted Sublicensee containing such terms as are standard for sublicense agreements in the biopharmaceutical industry.
Appears in 2 contracts
Samples: Exclusive License Agreement (Kairos Pharma, LTD.), Exclusive License Agreement (Kairos Pharma, LTD.)
Required Sublicensing. If Licensee is unable or unwilling to serve or develop a potential market or market territory for which there is a company willing to be a Permitted Sublicensee, Licensee will, at CSMC’s requestrequest (on behalf of Licensors), negotiate in good faith a sublicense with any such Permitted Sublicensee containing such terms as are standard for sublicense sub license agreements in the biopharmaceutical industry.
Appears in 1 contract
Required Sublicensing. If Licensee is unable or unwilling to serve or develop a potential market or market territory for which there is no then-current Permitted Sublicensee and there is a company willing to be a Permitted Sublicensee, Licensee will, at CSMC’s request, use commercially reasonable efforts to negotiate in good faith a sublicense with any such potential Permitted Sublicensee containing such terms as are standard for sublicense agreements in the biopharmaceutical industrySublicensee.
Appears in 1 contract
Samples: Exclusive License Agreement (9 Meters Biopharma, Inc.)
Required Sublicensing. If Licensee is unable or unwilling to serve or develop a potential market or market territory for which there is a company willing to be a Permitted Sublicensee, Licensee will, at CSMC’s request, negotiate in good faith a sublicense with any such Permitted Sublicensee containing such terms as are standard for sublicense agreements in the biopharmaceutical industrySublicensee.
Appears in 1 contract
Samples: Exclusive License Agreement (Synthetic Biologics, Inc.)